Sirtex: An education
I recently came across this excellent animated educational video produced by Sirtex Medical US, showing how their core medical device, SIR-Spheres, are delivered to inoperable tumours in the liver.
After watching this demonstration and gaining a better understanding of the treatment and its delivery, what should become clear is that there are other organs in the body that can be treated through a similar method.
In time, the possibility exists (if Sirtex can gain approval from the necessary regulators) for SIR-Spheres to also be used in treating cancerous tumours in the brain, lungs and even kidneys. Essentially: any site where there’s potential for the device to be delivered directly through a catheter or artery.
In regards to kidneys, for the first time Sirtex updated the market the other day on their clinical study of SIRT for the treatment of renal cell carcinoma (RCC) – the main type of cancer affecting the kidney. The update can be read here.
Whilst such an application has a much smaller potential market than the metastatic colorectal cancer of the liver, the announcement gives further indication of Sirtex’s exciting device being able to be used for other sufferers of this insipid disease. It’s yet is another step in the right direction.
This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.INVEST WITH MONTGOMERY